Publisher
Springer International Publishing
Reference67 articles.
1. Brito-Zerón, P., Bosch, X., Pérez-de-Lis, M., Pérez-Álvarez, R., Fraile, G., Gheitasi, H., et al. (2016). Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies. Seminars in Arthritis and Rheumatism, 45(4), 391–399.
2. Collamer, A., & Arroyo, R. (2010). Bone marrow hemophagocytosis complicating rheumatoid arthritis. Journal of Clinical Rheumatology, 16(3), 151.
3. Niang, A., Diallo, S., Ka, M. M., Pouye, A., Diop, S., Ndongo, S., et al. (2004). Hemophagocytic syndrome complicating adult’s seropositive rheumatoid arthritis. La Revue de Médecine Interne, 25(11), 826–828.
4. Ricci, M., Rossi, P., De Marco, G., Varisco, V., & Marchesoni, A. (2010). Macrophage activation syndrome after leflunomide treatment in an adult rheumatoid arthritis patient. Rheumatology (Oxford, England), 49(10), 2001.
5. Sandhu, C., Chesney, A., Piliotis, E., Buckstein, R., & Koren, S. (2007). Macrophage activation syndrome after etanercept treatment. The Journal of Rheumatology, 34(1), 241–242.